Breakthrough’ therapy for the most common type of leukaemia among children approved in Singapore Toggle share menu
Advertisement Breakthrough’ therapy for the most common type of leukaemia among children approved in Singapore
White blood cells are removed, genetically modified to attack cancer cells and put back into patients, in a treatment that was recently approved in Singapore. (Photo: Novartis)
24 Apr 2021 06:10AM) Share this content
SINGAPORE: A type of cell therapy for
cancer has been approved for use in Singapore, providing another treatment option for patients with certain types of advanced blood cancers which are not in remission despite having gone through other forms of treatment.